German oncologist, developer Covid vaccine
Stay or go? Biontech employees at the Mainz headquarters are losing patience: Job cuts and a new Sahin company: For months, the future of Biontech’s Mainz ...
echo-online.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/bleiben-oder-gehen-biontech-mitarbeitern-reisst-geduldsfaden-6568771
The restart of the BioNTech founders: This is what the financial restart of the BioNTech founders could look like
manager-magazin.de/unternehmen/industrie/biontech-gruender-wie-ugur-sahin-und-oezlem-tuereci-ihr-neues-start-up-finanzieren-wollen-a-05208c93-2d49-4985-8154-cd6808d801de
Paid articlePaywall
Key FactsBiontech announces closure of three sites from 2027
Sep 29, 2026 · Reading time: ~30 sec.
Summary created with AI assistance · Source: handelsblatt.com
Summary created with AI assistance · Source: handelsblatt.com
- The closures are scheduled for Tübingen in late 2027, Marburg in early 2028 and Idar-Oberstein in late 2028.
- According to the company, the decision affects about 1,800 employees, nearly one-quarter of Biontech’s workforce.
- Biontech attributed the failed months-long search mainly to difficult market and investment conditions.
- Biontech agreed additional severance terms with the group works council, but initially disclosed no details.
Pharma: “Expropriation of One’s Own Company” – Controversy Over the Biontech Legacy
handelsblatt.com/unternehmen/industrie/pharma-enteignung-der-eigenen-firma-eklat-um-das-erbe-von-biontech/100254498.html
Bernd Förtsch on BioNTech: Resignation is overdue: Shareholder Bernd Förtsch sharply criticizes the events at the Corona superstar.
deraktionaer.de/artikel/aktien/bernd-foertsch-ueber-biontech-ruecktritt-ist-ueberfaellig-20409989.html
Spin-off threatens to escalate: BioNTech founders clash with their own company: Billions in losses, job cuts, and a devastating top-down dispute: After the boom ...
n-tv.de/wirtschaft/Biontech-Gruender-verkrachen-sich-mit-eigenem-Unternehmen-id31361662.html
Sahin and Türeci stay: A success story for Mainz: BioNTech founders Ugur Şahin and Özlem Türeci are establishing their new company Arife in Mainz ...
allgemeine-zeitung.de/lokales/mainz/stadt-mainz/sahin-und-tuereci-bleiben-eine-erfolgsmeldung-fuer-mainz-6476567
Paid articlePaywall
Dispute over spin-off: Are the former bosses hollowing out BioNTech?: Uğur Şahin and Özlem Türeci plan to leave BioNTech and found a new company in 2027 ...
boerse-online.de/nachrichten/aktien/streit-um-abspaltung-hoehlen-die-ex-chefs-biontech-aus-20409499.html
Mit Guido Oelkers hat Biontech einen Nachfolger für den scheidenden Chef Uğur Şahin gefunden. Er soll schnell für neue Umsatzbringer sorgen – denn die Erlöse ... Show more
Bernd Förtsch, publisher of DER AKTIONÄR, has submitted a comprehensive list of questions to #BioNTech SE. The focus is on the spin-off of significant assets to a ... Show more
DER AKTIONÄR - | Germany's leading stock market magazine since 1996
DER AKTIONÄR - | Germany's leading stock market magazine since 1996
“I want to know what’s going on”: BioNTech heroes Özlem Türeci and Uğur Şahin face investor frustration as interest in the biotech company declines ...
deraktionaer.de/artikel/deraktionaermagazin/ich-will-wissen-was-sache-ist-20403071.html
Biotechnology: This is what the separation plan with the founders looks like at BioNTech
handelsblatt.com/unternehmen/industrie/biotechnologie-so-sieht-der-trennungsplan-bei-biontech-mit-den-gruendern-aus/100229675.html
Paid articlePaywall
OpinionCommentary: BioNTech founders Türeci and Şahin remain heroes: Özlem Türeci and Uğur Şahin are stepping down from biotech leadership to fight cancer with their ...
augsburger-allgemeine.de/wirtschaft/die-biontech-gruender-tuereci-und-sahin-bleiben-helden-114307503
Site closures tear BioNTech apart - | and also the founders Sahin and Türeci: Das harte Vorgehen gegen die Belegschaft zerreißt Biontech. Die Vorwürfe gegen ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-kahlschlag-zerreisst-auch-gruender-sahin-und-tuereci-5686497
Paid articlePaywall
Union: The mask has fallen at BioNTech: There is great uncertainty among the employees: Are there potential buyers for the plants? Can jobs be saved?
giessener-allgemeine.de/wirtschaft/gewerkschaft-bei-biontech-ist-die-maske-gefallen-zr-94319617.html
Massive job cuts at BioNTech: "We wonder if Ugur Şahin still knows what's happening in his company"
manager-magazin.de/unternehmen/industrie/biontech-betriebsrat-wirft-konzern-blockade-bei-standortverkaeufen-vor-a-b0ba0508-05a0-4cf6-b176-0604faa587bf
Key FactsBiontech Focuses on Cancer, Cuts Nearly 2000 Jobs
May 5, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: faz.net
Summary created with AI assistance · Source: faz.net
- Biontech will cease production of its COVID-19 vaccine Comirnaty and transfer manufacturing entirely to Pfizer.
- The company is prioritizing cancer drug research, investing €557 million in R&D during Q1 2026.
- Production facilities in Idar-Oberstein, Marburg, Singapore, and Curevac sites will close by the end of 2027, affecting 1860 employees.
- Cost savings are expected to reach €500 million yearly to support commercialization of its oncology product pipeline.
For many Biontech employees, a future vision is currently being dashed— IGBCE, represented by Roland Strasser, head of the IGBCE regional district Rhineland-Palatinate-Saarland
BioNTech CEO Şahin: “Socially responsible solutions will be offered to all those affected”
manager-magazin.de/unternehmen/industrie/allen-betroffenen-werden-sozialvertraegliche-loesungen-angeboten-a-d473e217-6e15-41cf-a740-71999a56dcf9
Sahin and Türeci's new company is causing concern among BioNTech employees: At the BioNTech company meeting in Mainz, the mood among the workforce was somber ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/sahins-neues-unternehmen-macht-biontech-belegschaft-kummer-5710800
Paid articlePaywall
After Curevac exit—Biontech co-founder pledges support to affected employees: Following the end of the COVID-19 pandemic, Biontech is refocusing on the ...
stuttgarter-nachrichten.de/inhalt.nach-curevac-aus-biontech-mitbegruender-sichert-betroffenen-mitarbeitern-unterstuetzung-zu.b6dd294c-13f1-4971-8141-1a9521f59533.html
Biontech: How the Şahin and Türeci couple dismantle themselves: Biontech is halting vaccine production in Germany. This is bad news for the country.
sueddeutsche.de/wirtschaft/biontech-stellenabbau-ugur-sahin-oezlem-tuereci-li.3479043
Paid articlePaywall
“Inevitable Change”: Why Biontech Founders Şahin and Türeci Really Left: More Scientists Than Managers: Şahin and Türeci struggled with the transformation of ...
spiegel.de/wirtschaft/unternehmen/biontech-warum-die-gruender-ugur-sahin-und-oezlem-tuereci-wirklich-gegangen-sind-a-82d56afb-a620-4086-a289-d79af1e1eb46
Paid articlePaywall Schwächen im Management: „Unumgänglicher Wechsel“ – warum die Biontech-Gründer wirklich gegangen sind
manager-magazin.de/unternehmen/pharma/biontech-warum-die-gruender-wirklich-gegangen-sind-unumgaenglicher-wechsel-a-00e5c1bf-56e6-40b2-b0ae-dc44a890ee9f
Paid articlePaywall BioNTech: The departure of founders Sahin and Türeci is (almost) forgotten: The departure of the BioNTech founders also caused a stir on the stock market ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-sahins-und-tuerecis-rueckzug-fast-schon-vergessen-5630001
Paid articlePaywall BioNTech founders Sahin/Türeci and Bill Gates: How they are connected: We show why it is likely that Bill Gates will invest in the new company of Ugur Sahin and ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/die-biontech-gruender-und-bill-gates-so-sind-sie-verbunden-5584941
Paid articlePaywall Earthquake at BioNTech 🚨 Six years ago, they were the heroes who gave the world the coronavirus vaccine. Now, the founding couple, Özlem Türeci and Uğur Şahin ... Show more
Key FactsBiontech Founders Launch New mRNA Venture
Mar 10, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: n-tv.de
Summary created with AI assistance · Source: n-tv.de
- Founders Ugur Sahin and Özlem Türeci plan to exit Biontech by late 2026 while retaining around 15 percent ownership.
- Their new company will focus on developing next-generation mRNA medicines, incorporating rights and technologies from Biontech.
- Biontech will receive a minority stake, licensing fees, and milestone payments in return for transferring assets.
- Biontech’s vaccine business remains unaffected as the founders shift their innovation efforts to a third biotech startup.
Özlem and I want to blaze new paths once again as pioneers.— Sahin said in a statement.
BioNTech after the turmoil: What happens to the company now?: BioNTech founders Şahin and Türeci plan to exit, investors worried, stock falls ...
deraktionaer.de/artikel/deraktionaerplus/biontech-nach-den-turbulenzen-was-passiert-jetzt-mit-dem-unternehmen-20397719.html
Paid articlePaywall Share swap - | Biontech launches offer to Curevac shareholders: The deadline for the share swap is December 3rd. The former competitors plan to conduct joint ...
stuttgarter-nachrichten.de/inhalt.aktientausch-biontech-startet-angebot-an-curevac-aktionaere.9753c233-bf64-4877-8fed-36fe7b77f02d.html
Biontech boss turns 60 - | the boy who wants to beat cancer: The "Lightspeed Project" of the first coronavirus vaccine catapults Ugur Sahin to the medical ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-chef-wird-60-der-junge-der-krebs-besiegen-will-4993255
Paid articlePaywall